Lymphoma is a heterogeneous group of malignancies, which comprises 4.2% of all new
cancer cases and 3.3% of all cancer deaths in 2019, globally. The dysregulation of immune …

Lymphomas are a diverse group of malignant proliferations that arise as discrete tissue
masses. The most widely accepted taxonomy for lymphoma is the World Health …

Despite the burden of anemia among Hodgkin lymphoma (HL) patients, data evaluating red
cell concentrate transfusion are limited. We retrospectively studied 285 newly diagnosed HL …

OBJETIVO: Caracterizar los pacientes con linfoma de Hodgkin en un centro de salud de alta
complejidad del área metropolitana de Medellín, Colombia. MÉTODO: Estudio de cohorte …

Hodgkin's lymphoma treatment outcomes have been the true success story of modern
medicine. Various data from western as well as Indian studies are available for classical …

Background: Hodgkin lymphoma (HL) is one of the most common malignancies affecting the
young Iraqi patients. This disease has diversified pathologies and clinical stages. Aims: To …

Background: Hodgkin's lymphoma (HL) is a malignancy of lymphatic glands whose
incidence is higher in Asia than in other continents and it is highly curable amongst other …

Uvod: Limfomi predstavljaju heterogenu grupu malignih oboljenja koja nastaju klonskom
prolifercijom limfocita u različitim stadijumima sazrevanja. Hočkinov limfom se javlja u 10 …

Background: An evaluation of the symptoms experienced by patients with lymphoma, the
reasons for admission and hospitalization, and the treatments admitted in the hospital are …

Background: Hodgkin's lymphoma is a clonal malignant lymphoid proliferation, which
originates from the germinal centers of B cells. This study was conducted to observe the …